TrialJournal of diabetes research2018

A Randomized Trial of Insulin Glargine plus Oral Hypoglycemic Agents versus Continuous Subcutaneous Insulin Infusion to Treat Newly Diagnosed Type 2 Diabetes.

Shuo Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.